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Melanoma is the most rapidly increasing malignancy among young people in the 
United States. If detected early, the disease is easily treated; however, once the 
disease has metastasized it is largely refractory to conventional therapies and is 
associated with a high mortality rate. The development of human cancer from a 
pre-malignant primary tumor to a metastatic lesion that develops at secondary 
sites is thought to be a multi-step process, requiring many genetic and epigenetic 
events that provide a growth advantage to cells. It is still unclear which of the 
many genetic changes in human cancers are required for metastasis. Therefore, 
it is critical to evaluate each step in the metastatic process. To this end, we will 
generate novel lentiviral vectors containing fluorescent reporter genes to better 
understand the metastatic potential of melanoma cells. Vectors containing green 
fluorescent protein (GFP) have already been generated while vectors containing 
red fluorescent protein (RFP) and yellow fluorescent protein (YFP) will be cloned. 
Viruses will be generated and used to infect syngeneic explanted tumor cells. 
Since each vector will be marked with a reporter gene of a different color, we will 
be able to track the movement of these cells in vivo and determine the source of 
each metastatic tumor. Whole body fluorescence will be detected using the 
FluorVivo Imaging System (INDEC BioSystems, Santa Clara, CA). The 
experiments proposed will contribute to an increased understanding of the 
biology of melanoma, which has the potential to identify specific molecular 
targets and promote the development of more effective therapies for advanced 
stages of this disease.   
 
24  
